Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

APOTEX INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 24
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

TEVA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 24
  • 0 comments

FDA approve ETODOLAC

Comment Full text

RK PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 26
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

APOTEX INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 30
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

TEVA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 30
  • 0 comments

FDA approve ETODOLAC

Comment Full text

ANI PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 22
  • 0 comments

FDA approve ETODOLAC

Comment Full text

CHARTWELL MOLECULES

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 23
  • 0 comments

FDA approve ETODOLAC

Comment Full text

ACTAVIS LABS FL INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 26
  • 0 comments

FDA approve KETOPROFEN

Comment Full text

ACTAVIS MID ATLANTIC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 21
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

IMPAX LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 22
  • 0 comments

FDA approve NABUMETONE

Comment Full text
  • Previous
  • 202
  • 203
  • 204
  • 205
  • 206
  • Next

Search

News categories

  • Technical Exchange News(9888)
  • Event(409)
  • SEC News(167433)
  • FDA Approval(9349)
  • Company Report(721)
  • Business News(111284)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin